PDF(Pubmed)
Abstract：
UNASSIGNED: Patients with primary brain tumours (i.e., neuro-oncology patients) lack access to exercise oncology and wellness resources. The purpose of the Alberta Cancer Exercise - Neuro-Oncology (ACE-Neuro) study is to assess the feasibility of a tailored neuro-oncology exercise program for patients across Alberta, Canada. The primary outcome is to assess the feasibility of ACE-Neuro. The secondary outcome is to examine preliminary effectiveness of ACE-Neuro on patient-reported outcomes and functional fitness.
UNASSIGNED: Neuro-oncology patients with a malignant or benign primary brain tumour that are pre, on, or completed treatment, are >18 years, and able to consent in English are eligible to participate in the study. Following referral from the clinical team to cancer rehabilitation and the study team, participants are triaged to determine their appropriateness for ACE-Neuro and other cancer rehabilitation services (including physiatry, physiotherapy, occupational therapy, and exercise physiology). In ACE-Neuro, participants complete a tailored 12-week exercise program with pre-post assessments of patient-reported outcomes and functional fitness, and objective physical activity tracked across the 12-week program. ACE-Neuro includes individual and group-based exercise sessions, as well as health coaching.
UNASSIGNED: We are supporting ACE-Neuro implementation into clinical cancer care, with assessment of needs enabling a tailored exercise prescription.
UNASSIGNED: Neuro-oncology patients with a malignant or benign primary brain tumour that are pre, on, or completed treatment, are >18 years, and able to consent in English are eligible to participate in the study. Following referral from the clinical team to cancer rehabilitation and the study team, participants are triaged to determine their appropriateness for ACE-Neuro and other cancer rehabilitation services (including physiatry, physiotherapy, occupational therapy, and exercise physiology). In ACE-Neuro, participants complete a tailored 12-week exercise program with pre-post assessments of patient-reported outcomes and functional fitness, and objective physical activity tracked across the 12-week program. ACE-Neuro includes individual and group-based exercise sessions, as well as health coaching.
UNASSIGNED: We are supporting ACE-Neuro implementation into clinical cancer care, with assessment of needs enabling a tailored exercise prescription.
摘要：
■原发性脑肿瘤患者(即，神经肿瘤患者）缺乏运动肿瘤和健康资源。艾伯塔省癌症运动-神经肿瘤学（ACE-Neuro）研究的目的是评估为整个艾伯塔省患者量身定制的神经肿瘤学运动计划的可行性。加拿大。主要结果是评估ACE-Neuro的可行性。次要结果是检查ACE-Neuro对患者报告的结果和功能适应性的初步有效性。
■患有恶性或良性原发性脑肿瘤的神经肿瘤患者，on,或完成治疗，>18岁，并且能够用英语同意才有资格参加研究。在从临床团队转诊到癌症康复和研究团队之后，参与者被分诊，以确定他们是否适合ACE-Neuro和其他癌症康复服务(包括理疗，物理治疗,职业治疗,和运动生理学)。在ACE-Neuro,参与者完成了一项量身定制的12周锻炼计划，并对患者报告的结果和功能适应性进行了事后评估。以及在12周计划中跟踪的客观身体活动。ACE-Neuro包括个人和团体锻炼，以及健康教练。
■我们正在支持ACE-Neuro在临床癌症护理中的实施，对需求进行评估，从而制定量身定制的运动处方。
■患有恶性或良性原发性脑肿瘤的神经肿瘤患者，on,或完成治疗，>18岁，并且能够用英语同意才有资格参加研究。在从临床团队转诊到癌症康复和研究团队之后，参与者被分诊，以确定他们是否适合ACE-Neuro和其他癌症康复服务(包括理疗，物理治疗,职业治疗,和运动生理学)。在ACE-Neuro,参与者完成了一项量身定制的12周锻炼计划，并对患者报告的结果和功能适应性进行了事后评估。以及在12周计划中跟踪的客观身体活动。ACE-Neuro包括个人和团体锻炼，以及健康教练。
■我们正在支持ACE-Neuro在临床癌症护理中的实施，对需求进行评估，从而制定量身定制的运动处方。
